R. Soller, C. Shaheen, J. Yen, J. Rose, J. Lightwood
{"title":"非处方非甾体抗炎药药物过敏预警的改进","authors":"R. Soller, C. Shaheen, J. Yen, J. Rose, J. Lightwood","doi":"10.1177/0092861512440951","DOIUrl":null,"url":null,"abstract":"Objective The purpose of the study was to compare revised and current ibuprofen over-the-counter (OTC) allergy alerts for usability, readability, and overall preferences in consumers naive to drug allergies and drug-induced allergy survivors. Methods Label comprehension studies in naive consumers and survivors used standard measures for usability, readability, and preferences to rate new versus current content and format regarding time of onset, onset after prior safe use, syndrome name, progressive nature, symptoms, and use of capital letters. Results The revised allergy alert was statistically superior to the current alert as reported by all participants for overall preference, most new key content elements, and usefulness for first-time users (for each, P <.001). Survivors agreed the new alert applied to their drug allergy experience ( P <.001). Conclusions There is a gap of key information in the current OTC ibuprofen allergy alerts, demonstrating the need for revision of the OTC Drug Facts label.","PeriodicalId":391574,"journal":{"name":"Drug information journal : DIJ / Drug Information Association","volume":"39 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2012-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":"{\"title\":\"Improvement of the Drug Allergy Alert for Nonprescription NSAIDs\",\"authors\":\"R. Soller, C. Shaheen, J. Yen, J. Rose, J. Lightwood\",\"doi\":\"10.1177/0092861512440951\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective The purpose of the study was to compare revised and current ibuprofen over-the-counter (OTC) allergy alerts for usability, readability, and overall preferences in consumers naive to drug allergies and drug-induced allergy survivors. Methods Label comprehension studies in naive consumers and survivors used standard measures for usability, readability, and preferences to rate new versus current content and format regarding time of onset, onset after prior safe use, syndrome name, progressive nature, symptoms, and use of capital letters. Results The revised allergy alert was statistically superior to the current alert as reported by all participants for overall preference, most new key content elements, and usefulness for first-time users (for each, P <.001). Survivors agreed the new alert applied to their drug allergy experience ( P <.001). Conclusions There is a gap of key information in the current OTC ibuprofen allergy alerts, demonstrating the need for revision of the OTC Drug Facts label.\",\"PeriodicalId\":391574,\"journal\":{\"name\":\"Drug information journal : DIJ / Drug Information Association\",\"volume\":\"39 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-04-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug information journal : DIJ / Drug Information Association\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/0092861512440951\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug information journal : DIJ / Drug Information Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/0092861512440951","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4
摘要
目的本研究的目的是比较修订后的和现行的非处方布洛芬(OTC)过敏警报的可用性、可读性和对药物过敏的新手消费者和药物性过敏幸存者的总体偏好。方法在幼稚消费者和幸存者中进行标签理解研究,使用可用性、可读性和偏好的标准措施,对新的内容和格式进行评分,包括发病时间、先前安全使用后的发病、综合征名称、进行性、症状和大写字母的使用。结果修订后的过敏警报在总体偏好、大多数新的关键内容元素和首次使用者的有用性方面优于所有参与者报告的当前警报(各P < 0.001)。幸存者同意新的警告适用于他们的药物过敏经历(P < 0.001)。结论目前的OTC布洛芬过敏警示中存在关键信息的缺失,需要对OTC Drug Facts标签进行修订。
Improvement of the Drug Allergy Alert for Nonprescription NSAIDs
Objective The purpose of the study was to compare revised and current ibuprofen over-the-counter (OTC) allergy alerts for usability, readability, and overall preferences in consumers naive to drug allergies and drug-induced allergy survivors. Methods Label comprehension studies in naive consumers and survivors used standard measures for usability, readability, and preferences to rate new versus current content and format regarding time of onset, onset after prior safe use, syndrome name, progressive nature, symptoms, and use of capital letters. Results The revised allergy alert was statistically superior to the current alert as reported by all participants for overall preference, most new key content elements, and usefulness for first-time users (for each, P <.001). Survivors agreed the new alert applied to their drug allergy experience ( P <.001). Conclusions There is a gap of key information in the current OTC ibuprofen allergy alerts, demonstrating the need for revision of the OTC Drug Facts label.